Breaking News Instant updates and real-time market news.

SAGE

SAGE Therapeutics

$45.64

-0.41 (-0.89%)

07:26
10/04/16
10/04
07:26
10/04/16
07:26

SAGE Therapeutics reinstated with an Outperform at Leerink

Leerink analyst Paul Matteis resumed coverage of SAGE Therapeutics with an Outperform rating and $68 price target.

  • 07

    Oct

  • 06

    Nov

SAGE SAGE Therapeutics
$45.64

-0.41 (-0.89%)

08/10/16
RHCO
08/10/16
NO CHANGE
RHCO
SAGE Therapeutics shares should be bought following decline, says SunTrust
After SAGE announced that the results of a Phase III trial of its SRSE drug would be delayed until 1H17 from 2H16 due to slower than expected enrollment, SunTrust analyst Edward Nash says the delay does not affect his timetable for the drug's commercial launch. The analyst does not expect changes to the protocol amendment to meaningfully affect patient characteristics or the results. He reiterates a $95 price target and Buy rating on the shares.
09/06/16
ADAM
09/06/16
NO CHANGE
Target $110
ADAM
Buy
SAGE Therapeutics breakthrough designation rare for FDA, says Canaccord
Canaccord analyst John Newman said SAGE Therapeutics' breakthrough designation for SAGE-547 is rare for the FDA to give in central nervous system disorders, suggesting the agency was impressed with the clinical data. Newman expects the breakthrough status to shorten the regulatory timing and allow for more flexibility in study design. The analyst rates SAGE a Buy with a $110 price target.
09/07/16
ROTH
09/07/16
NO CHANGE
Target $149
ROTH
Buy
Ligand has 'major catalyst' ahead, says Roth Capital
Roth Capital analyst Joseph Pantginis says Ligand (LGND) is expecting a "major catalyst" this month namely the Phase IIb sparsentan data in focal segmental glomerulosclerosis patients being developed by partner Retrophin (RTRX). In a separate note to investors, Pantginis also said that the Breakthrough Therapy Designation of SAGE Therapeutics' (SAGE) '547 for postpartum depression may expedite its development and approval for use in the clinic, noting that the company has an agreement of 3% royalty payment to Ligand for potential sales of the drug. The analyst recommends steady accumulation of Ligand's stock as he anticipates that current revenue streams from partnered products and the broad "in development" portfolio are poised to drive significant growth in the near and longer term. He reiterates a Buy rating and $149 price target on Ligand's shares.
09/13/16
RAJA
09/13/16
INITIATION
Target $75
RAJA
Outperform
SAGE Therapeutics initiated with an Outperform at Raymond James
Raymond James analyst Christopher Raymond initiated SAGE Therapeutics with an Outperform and a $75 price target. Raymond likes the setup on SAGE shares as key validation of its unique central nervous system drug development approach nears through pivotal SAGE-547 data, expected 1H 2017. Combining this with a pipeline holding numerous unmodeled call options and a platform capable of generating novel agents in a space lacking innovation, he believes shares will move higher.

TODAY'S FREE FLY STORIES

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

, BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

21:24
04/23/17
04/23
21:24
04/23/17
21:24
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

WFC

Wells Fargo

$53.00

-0.5 (-0.93%)

UAL

United Continental

$69.56

-0.24 (-0.34%)

ALBO

Albireo Pharma

$20.66

-0.26 (-1.24%)

BMY

Bristol-Myers

$53.48

0.04 (0.07%)

ABUS

Arbutus Biopharma

MRK

Merck

$61.89

-0.66 (-1.06%)

SRPT

Sarepta

$32.61

0.07 (0.22%)

JNJ

Johnson & Johnson

$121.76

-0.11 (-0.09%)

MGM

MGM Resorts

$28.41

-0.05 (-0.18%)

AA

Alcoa

$31.70

-0.34 (-1.06%)

ORLY

O'Reilly Automotive

$265.36

2.36 (0.90%)

SRG

Seritage Growth Properties

$42.86

-0.47 (-1.08%)

C

Citi

$57.72

-0.69 (-1.18%)

GS

Goldman Sachs

$216.86

-1.2 (-0.55%)

BAC

Bank of America

$22.71

-0.36 (-1.56%)

JPM

JPMorgan

$84.52

-1.03 (-1.20%)

MS

Morgan Stanley

$41.80

-0.7 (-1.65%)

INFY

Infosys

$14.48

0.01 (0.07%)

HOG

Harley-Davidson

$55.81

-0.66 (-1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 29

    Apr

  • 02

    May

  • 02

    May

  • 03

    May

  • 04

    May

  • 07

    May

  • 09

    May

  • 10

    May

  • 11

    May

  • 19

    May

  • 22

    May

  • 27

    May

  • 06

    Jun

  • 06

    Jun

  • 07

    Jun

  • 09

    Jun

  • 14

    Jun

  • 13

    Jul

  • 14

    Jul

  • 18

    Jul

  • 25

    Jul

  • 12

    Oct

  • 12

    Oct

  • 17

    Oct

  • 15

    Jan

  • 13

    Apr

  • 13

    Jul

  • 12

    Oct

KMB

Kimberly-Clark

$129.96

-1.27 (-0.97%)

, HLX

Helix Energy

$7.09

-0.19 (-2.61%)

20:25
04/23/17
04/23
20:25
04/23/17
20:25
Earnings
Notable companies reporting before Monday's open »

Notable companies…

KMB

Kimberly-Clark

$129.96

-1.27 (-0.97%)

HLX

Helix Energy

$7.09

-0.19 (-2.61%)

HAS

Hasbro

$96.03

0.02 (0.02%)

HAL

Halliburton

$47.06

-0.63 (-1.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 01

    May

  • 01

    May

  • 17

    May

  • 18

    May

20:20
04/23/17
04/23
20:20
04/23/17
20:20
Hot Stocks
White House budget director: Tax announcement likely to be broad guidance, ideas »

Speaking in a Fox News…

20:02
04/23/17
04/23
20:02
04/23/17
20:02
Hot Stocks
President Trump: 'Big' tax reform, tax reduction to be announced Wednesday »

President Donald Trump…

WFC

Wells Fargo

$53.00

-0.5 (-0.93%)

19:59
04/23/17
04/23
19:59
04/23/17
19:59
Periodicals
Reelection vote counts show several Wells Fargo directors at risk, WSJ says »

Several Wells Fargo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 11

    May

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

BEBE

bebe stores

$4.00

0.2401 (6.39%)

19:39
04/23/17
04/23
19:39
04/23/17
19:39
Hot Stocks
bebe stores to close all locations by end of May »

bebe stores disclosed in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$53.00

-0.5 (-0.93%)

19:34
04/23/17
04/23
19:34
04/23/17
19:34
Periodicals
Two California retirement systems vote against Wells directors, Reuters says »

Two of California's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 11

    May

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

AAL

American Airlines

$45.15

-0.07 (-0.15%)

, UAL

United Continental

$69.56

-0.24 (-0.34%)

19:22
04/23/17
04/23
19:22
04/23/17
19:22
Periodicals
American Airlines suspends flight attendant after Friday altercation, WSJ says »

Video of an American…

AAL

American Airlines

$45.15

-0.07 (-0.15%)

UAL

United Continental

$69.56

-0.24 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

FB

Facebook

$143.68

-0.12 (-0.08%)

19:11
04/23/17
04/23
19:11
04/23/17
19:11
Periodicals
Facebook seeks deals with publishers for video production, Recode says »

As part of a bid to push…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

HLX

Helix Energy

$7.09

-0.19 (-2.61%)

18:25
04/23/17
04/23
18:25
04/23/17
18:25
Earnings
Helix Energy reports Q1 EPS (11c), consensus (13c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 01

    May

CMCSA

Comcast

$38.16

0.16 (0.42%)

, CMCSK

Comcast

18:17
04/23/17
04/23
18:17
04/23/17
18:17
Hot Stocks
Box Office Battle: 'Fate Of The Furious' nears global $1B in second weekend »

Comcast's (CMCSA)…

CMCSA

Comcast

$38.16

0.16 (0.42%)

CMCSK

Comcast

FOX

21st Century Fox

$30.22

-0.33 (-1.08%)

FOXA

21st Century Fox

$30.70

-0.37 (-1.19%)

DIS

Disney

$114.44

-0.35 (-0.30%)

TWX

Time Warner

$99.84

-0.16 (-0.16%)

LGF.A

Lionsgate

$26.08

0.11 (0.42%)

LGF.B

Lionsgate

$23.90

0.01 (0.04%)

SNE

Sony

$33.68

0.85 (2.59%)

VIA

Viacom

$45.05

-1 (-2.17%)

VIAB

Viacom

$43.10

-1.23 (-2.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 03

    May

  • 04

    May

  • 10

    May

  • 24

    May

  • 25

    May

  • 15

    Jun

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

, BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

17:46
04/23/17
04/23
17:46
04/23/17
17:46
Earnings
C.R. Bard raises FY17 adjusted EPS to $11.65-$11.90 from $11.45-$11.75 »

EPS consensus $11.64.…

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

, BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

17:43
04/23/17
04/23
17:43
04/23/17
17:43
Earnings
C.R. Bard sees Q2 adjusted EPS $2.75-$2.85, consensus $2.87 »

Sees Q2 revenue growth…

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

, BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

17:41
04/23/17
04/23
17:41
04/23/17
17:41
Earnings
C.R. Bard reports Q1 adjusted EPS $2.87, consensus $2.65 »

Reports Q1 revenue…

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

, BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

17:38
04/23/17
04/23
17:38
04/23/17
17:38
Hot Stocks
Becton Dickinson names Polen as president, says will lead Bard segment »

BD (BDX) announced the…

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

HCMLY

LafargeHolcim

$11.56

-0.1 (-0.86%)

17:32
04/23/17
04/23
17:32
04/23/17
17:32
Periodicals
LafargeHolcim CEO set to step down, FT reports »

LafargeHolcim CEO Eric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

, BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

17:30
04/23/17
04/23
17:30
04/23/17
17:30
Hot Stocks
Becton Dickinson outlines strategic highlights of C.R. Bard acquisition »

Expanding on the…

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

KLRE

KLR Energy Acquisition

$10.40

-0.02 (-0.19%)

17:29
04/23/17
04/23
17:29
04/23/17
17:29
Conference/Events
KLR Energy Acquisition to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

, BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

17:23
04/23/17
04/23
17:23
04/23/17
17:23
Hot Stocks
BD sees forming third business segment, says Bard CEO to join board »

Commenting on its…

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

, BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

17:20
04/23/17
04/23
17:20
04/23/17
17:20
Hot Stocks
BD sees high single-digit EPS accretion in FY19 »

"This financially…

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

, BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

17:18
04/23/17
04/23
17:18
04/23/17
17:18
Hot Stocks
Becton Dickinson says expects to continue buyback suspension »

"BD expects to…

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

, BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

17:16
04/23/17
04/23
17:16
04/23/17
17:16
Hot Stocks
Becton Dickinson to acquire C.R. Bard in $24B cash and stock deal »

BD (BDX) and C. R. Bard…

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

, BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

17:10
04/23/17
04/23
17:10
04/23/17
17:10
Hot Stocks
Breaking Hot Stocks news story on Becton Dickinson, C.R. Bard »

Becton Dickinson to…

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

CS

Credit Suisse

$14.45

-0.09 (-0.62%)

17:07
04/23/17
04/23
17:07
04/23/17
17:07
Periodicals
Credit Suisse to determine capital raise plan after annual meeting, Reuters says »

Credit Suisse will make a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$142.27

-0.17 (-0.12%)

17:04
04/23/17
04/23
17:04
04/23/17
17:04
Periodicals
Uber CEO ordered iPhone tracking, was scolded by Tim Cook, NYT says »

Beginning in 2014, ride…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.